ZELTIQ Aesthetics (ZLTQ) : $1.11 million worth of transactions were on upticks in ZELTIQ Aesthetics (ZLTQ), compared to $0.71 million on downticks. The ratio between the two was 1.57, whereas, the net money flow stood at a healthy $0.4 million on Fridays session. The consistent buying on upticks in the stock accounted for $0million worth of trades. The total money flow into the stock stood at $0 million. The bulls and the bears were in an equilibrium as the stock closed with a loss of -0.08%. The stock was trading at $38.18, with a drop of $0.03 over the previous days close. The stock recorded 2.06% for the week.
The company Insiders own 15.6% of ZELTIQ Aesthetics shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -6.33% . During last six month period, the net percent change held by insiders has seen a change of -13.58%.
In a related news,The director officer (President and CEO) of Zeltiq Aesthetics Inc, Foley Mark J sold 10,000 shares at $37.26 on August 15, 2016. The Insider selling transaction had a total value worth of $372,600. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
ZELTIQ Aesthetics (NASDAQ:ZLTQ): stock was range-bound between the intraday low of $37.82 and the intraday high of $38.31 after having opened at $38.22 on Fridays session. The stock finally closed in the red at $38.22, a loss of -0.37%. The stock remained in the red for the whole trading day. The total traded volume was 421,192 shares. The stock failed to cross $38.31 in Fridays trading. The stocks closing price on Thursday was $38.21.
ZELTIQ Aesthetics (ZLTQ) : Traders are bullish on ZELTIQ Aesthetics (ZLTQ) as it has outperformed the S&P 500 by a wide margin of 8.64% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 1.25%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 1.76% in the last 1 week, and is up 8.49% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells, which are needed to perform procedures using its CoolSculpting system. As of December 31, 2014, it had an installed base of 3,176 CoolSculpting systems installed across approximately 2,688 practices across the world. As of December 31, 2014, 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.